Cargando…

Correction to: Candidemia in a major regional tertiary referral hospital – epidemiology, practice patterns and outcomes

Detalles Bibliográficos
Autores principales:	Teo, Jocelyn Qi-Min, Candra, Samuel Rocky, Lee, Shannon Jing-Yi, Chia, Shannon Yu-Hng, Leck, Hui, Tan, Ai-Ling, Neo, Hui-Peng, Leow, Kenneth Wei-Liang, Cai, Yiying, Ee, Pui Lai Rachel, Lim, Tze-Peng, Lee, Winnie, Kwa, Andrea Lay-Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223032/ https://www.ncbi.nlm.nih.gov/pubmed/30455868 http://dx.doi.org/10.1186/s13756-018-0413-2

Ejemplares similares

Candidemia in a major regional tertiary referral hospital – epidemiology, practice patterns and outcomes
por: Teo, Jocelyn Qi-Min, et al.
Publicado: (2017)

Clinical Experience with High-Dose Polymyxin B against Carbapenem-Resistant Gram-Negative Bacterial Infections—A Cohort Study
por: Cai, Yiying, et al.
Publicado: (2020)

Using an Adenosine Triphosphate Bioluminescent Assay to Determine Effective Antibiotic Combinations against Carbapenem-Resistant Gram Negative Bacteria within 24 Hours
por: Cai, Yiying, et al.
Publicado: (2015)

Molecular mechanisms of azole resistance in Candida bloodstream isolates
por: Teo, Jocelyn Qi-Min, et al.
Publicado: (2019)

Elimination of Extracellular Adenosine Triphosphate for the Rapid Prediction of Quantitative Plate Counts in 24 h Time-Kill Studies against Carbapenem-Resistant Gram-Negative Bacteria
por: Cai, Yiying, et al.
Publicado: (2020)

Carbapenem Resistance in Gram-Negative Bacteria: The Not-So-Little Problem in the Little Red Dot
por: Teo, Jocelyn Qi Min, et al.
Publicado: (2016)

Integrated pharmacokinetic–pharmacodynamic modeling to evaluate empiric carbapenem therapy in bloodstream infections
por: Lim, Tze-Peng, et al.
Publicado: (2018)

Risk Factors, Molecular Epidemiology and Outcomes of Ertapenem-Resistant, Carbapenem-Susceptible Enterobacteriaceae: A Case-Case-Control Study
por: Teo, Jocelyn, et al.
Publicado: (2012)

From Bench-Top to Bedside: A Prospective In Vitro Antibiotic Combination Testing (iACT) Service to Guide the Selection of Rationally Optimized Antimicrobial Combinations against Extensively Drug Resistant (XDR) Gram Negative Bacteria (GNB)
por: Cai, Yiying, et al.
Publicado: (2016)

Candida Surveillance in Surgical Intensive Care Unit (SICU) in a Tertiary Institution
por: Liew, Yi Xin, et al.
Publicado: (2015)

Treatment and Outcomes of Infections Caused by Diverse Carbapenemase-Producing Carbapenem-Resistant Enterobacterales
por: Lim, Fang Kang, et al.
Publicado: (2020)

In vitro Bactericidal Activities of Combination Antibiotic Therapies Against Carbapenem-Resistant Klebsiella pneumoniae With Different Carbapenemases and Sequence Types
por: Teo, Jocelyn Qi-Min, et al.
Publicado: (2021)

Epidemiology and Outcomes of Candidemia in a Referral Center in Tehran
por: Salehi, Mohammadreza, et al.
Publicado: (2019)

In Vitro Susceptibility to Ceftazidime-Avibactam and Comparator Antimicrobial Agents of Carbapenem-Resistant Enterobacterales Isolates
por: Lim, Tze-Peng, et al.
Publicado: (2023)

Effective Antibiotics in Combination against Extreme Drug-Resistant Pseudomonas aeruginosa with Decreased Susceptibility to Polymyxin B
por: Lim, Tze-Peng, et al.
Publicado: (2011)

Clinical Characteristics and Outcome of Candidemia: Experience from a Tertiary Referral Center in Saudi Arabia
por: Alhatmi, Hind, et al.
Publicado: (2022)

Clinical, epidemiological, and mycological features of patients with candidemia: Experience in two tertiary referral centers in Iran
por: Kord, Mohammad, et al.
Publicado: (2022)

Ceftolozane/Tazobactam Resistance and Mechanisms in Carbapenem-Nonsusceptible Pseudomonas aeruginosa
por: Teo, Jocelyn Qi-Min, et al.
Publicado: (2021)

Predictors and Outcomes of Healthcare-Associated Infections Caused by Carbapenem-Nonsusceptible Enterobacterales: A Parallel Matched Case-Control Study
por: Hoo, Grace S. R., et al.
Publicado: (2022)

Impact of Antimicrobial Stewardship Program (ASP) on Outcomes in Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) in an Acute-Tertiary Care Hospital
por: Loo, Li Wen, et al.
Publicado: (2015)

Reemergence of Intravenous Drug Use as Risk Factor for Candidemia, Massachusetts, USA
por: Poowanawittayakom, Nongnooch, et al.
Publicado: (2018)

Nosocomial candidemia in an Italian tertiary care hospital
por: Luzzati, R, et al.
Publicado: (1999)

Genomic characterization of carbapenem-non-susceptible Pseudomonas aeruginosa in Singapore
por: Teo, Jocelyn Qi-Min, et al.
Publicado: (2021)

Genomic Surveillance of Carbapenem-Resistant Klebsiella pneumoniae from a Major Public Health Hospital in Singapore
por: Teo, Jocelyn Qi-Min, et al.
Publicado: (2022)

Ocular Candidiasis in Patients with Candidemia at a Large Tertiary Care Center
por: Lee, Bonny, et al.
Publicado: (2017)

Estimating the economic cost of carbapenem resistant Enterobacterales healthcare associated infections in Singapore acute-care hospitals
por: Cai, Yiying, et al.
Publicado: (2022)

Extensively drug-resistant Acinetobacter baumannii in a Thai hospital: a molecular epidemiologic analysis and identification of bactericidal Polymyxin B-based combinations
por: Teo, Jocelyn, et al.
Publicado: (2015)

Nonattenuated Polymyxin B Used for the Treatment of Extreme-Drug Resistant Acinetobacter baumannii-Related Infections in Patients with Preexisting End Stage Renal Failure
por: Zhou, Yvonne Peijun, et al.
Publicado: (2014)

In-Vitro Activity of Polymyxin B, Rifampicin, Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii in Singapore
por: Lim, Tze-Peng, et al.
Publicado: (2011)

Risk Factors and Outcomes of Non-albicans Candida Bloodstream Infection in Patients with Candidemia at Siriraj Hospital—Thailand’s Largest National Tertiary Referral Hospital
por: Ngamchokwathana, Chaiyapong, et al.
Publicado: (2021)

Hematogenous Endophthalmitis in a Patient with Candidemia
por: Na, Sang Kyu, et al.
Publicado: (1997)

The Impact of Biofilm Formation on the Persistence of Candidemia
por: Li, Wei-Sin, et al.
Publicado: (2018)

Candida glabrata candidemia
por: Chakrabarti, Arunaloke
Publicado: (2015)

Candidemia en Colombia
por: Cortés, Jorge Alberto, et al.
Publicado: (2020)

1166. Evaluating the Impact of the 2016 Candidemia Guidelines on the Incidence of Ocular Complications of Candidemia
por: Hillenbrand, Molly, et al.
Publicado: (2020)

1722. The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Emerging Risk Factor for Candidemia
por: Zhang, Alexia Y, et al.
Publicado: (2018)

Incidence of candidemia and prevalence of azole-resistant candidemia at a tertiary South African hospital – A retrospective laboratory analysis 2016–2020
por: Chibabhai, Vindana
Publicado: (2022)

Candida dubliniensis candidemia in Australia.
por: Marriott, D, et al.
Publicado: (2001)

Active Surveillance of Candidemia, Australia
por: Chen, Sharon, et al.
Publicado: (2006)

Candidemia in Finland, 1995–1999
por: Poikonen, Eira, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_tidg73rd1gp19es75p4qaqagoo